Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders (Q24300724)

0 references

Rainer Ehling

0 references

Kathrin Schanda

0 references

Andreas Lutterotti

0 references

Claudia Brinkhoff

0 references

Thomas Oertle

0 references

Martin E Schwab

0 references

Florian Deisenhammer

0 references

Thomas Berger

0 references

Christine E Bandtlow

Journal of Neuroimmunology

0 references

language of work or name

English

0 references

publication date

December 2003

0 references

published in

0 references

volume

145

0 references

issue

1-2

0 references

page(s)

139-47

0 references

cites work

Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Oligodendroglial reaction following spinal cord injury in rat: transient upregulation of MBP mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Reactions of oligodendrocytes to spinal cord injury: cell survival and myelin repair.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

B cells and antibodies in CNS demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Pathogenetic role of autoantibodies in neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Inhibitor of neurite outgrowth in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Cytokines and acute neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Rapid induction of autoantibodies against Nogo‐A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Sprouting and regeneration of lesioned corticospinal tract fibres in the adult rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured purkinje cell axons.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Protective autoimmunity is a physiological response to CNS trauma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021

Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNEUROIM.2003.09.010

7 January 2021